Cyber Security

A monthslong global cyberespionage campaign that penetrated U.S. government agencies and involved a common software product used by thousands of organizations has left governments and major corporations scrambling to see if they too were victims of an attack.

The cyber hack backed by a foreign government on the U.S. Treasury Department and an agency within the Commerce Department is being taken “very seriously,” Commerce Secretary Wilbur Ross said.

“The United States government is aware of these reports and we are taking all necessary steps to identify and remedy any possible issues related to this situation,” National Security Council spokesman John Ullyot told FOX Business in a statement.

The Senate has narrowly approved President Donald Trump’s lame-duck nominee to become a member of the Federal Communications Commission, setting up the agency for a stretch of partisan gridlock likely to stymie President-elect Joe Biden’s policies.

Con artists have recently been using the names of big-name companies, including Apple and Amazon, to trick consumers, according to the Federal Trade Commission.

As the coronavirus vaccine becomes available this winter and into the spring, hackers will be sure to use news of the vaccine to their advantage, according to consumer credit reporting company Experian.

As the world awaits approval of one, or perhaps multiple vaccines for COVID-19, cybersecurity researchers at IBM say they have uncovered a global campaign to collect information on distributing the vaccine to developing countries.

A since-fixed iPhone vulnerability allowed hackers to control any iPhone within WiFi range, a Google researcher found.

A disgruntled former employee whose battle with Tesla and its founder, Elon Musk, played out in news outlets and on social media, has agreed to a settlement.

The U.S. saw a 427% increase in delivery and shipping-related scams amid Black Friday and Cyber Monday, according to data from cybersecurity firm Check Point Research.

Cyberattacks against health bodies, vaccine scientists and drugmakers have soared during the COVID-19 pandemic.